00:00/00:00
您的浏览器不支持 audio 标签。
Listen to this article
1x
Billions of dollars are pouring into China’s radiopharmaceutical industry as it races to catch up with global giants such as Novartis and its treatment Pluvicto.
In Depth: Where China Stands in the Nuclear Medicine Gold Rush
Billions are pouring into the domestic radiopharmaceutical industry as it races to catch up with global giants. But a shortage of talent and a ‘fast-follower’ mentality are proving to be major obstacles
1,175 words~5 min read
